Literature DB >> 16275829

Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4.

T L Huang1, P P Zandi, K L Tucker, A L Fitzpatrick, L H Kuller, L P Fried, G L Burke, M C Carlson.   

Abstract

OBJECTIVE: To compare associations of lean fish vs fatty fish (tuna or other fish) intake with dementia, Alzheimer disease (AD), and vascular dementia (VaD) and in relation to APOE epsilon4 status in the Cardiovascular Health Cognition Study (CHCS).
METHODS: Fish intake was assessed by food frequency questionnaires. Incident dementia, AD, and VaD were determined through a series of cognitive tests, physician's assessment, and committee consensus. We used Cox proportional hazards regression to calculate hazard ratios of dementia, AD, and VaD with lean fried fish, fatty fish, or total fish intake, which were then stratified by the presence of APOE epsilon4.
RESULTS: Although consumption of lean fried fish had no protective effect, consumption of fatty fish more than twice per week was associated with a reduction in risk of dementia by 28% (95% CI: 0.51 to 1.02), and AD by 41% (95% CI: 0.36 to 0.95) in comparison to those who ate fish less than once per month. Stratification by APOE epsilon4 showed this effect to be selective to those without the epsilon4 allele. Adjustment by education and income attenuated the effect.
CONCLUSION: In the Cardiovascular Health Cognition Study, consumption of fatty fish was associated with a reduced risk of dementia and Alzheimer disease for those without the APOE epsilon4 allele.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275829     DOI: 10.1212/01.wnl.0000183148.34197.2e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  103 in total

1.  Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging.

Authors:  G L Bowman; L C Silbert; D Howieson; H H Dodge; M G Traber; B Frei; J A Kaye; J Shannon; J F Quinn
Journal:  Neurology       Date:  2011-12-28       Impact factor: 9.910

Review 2.  Vascular basis for brain degeneration: faltering controls and risk factors for dementia.

Authors:  Raj N Kalaria
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

Review 3.  Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Biochem Pharmacol       Date:  2014-01-04       Impact factor: 5.858

Review 4.  Diet, cognition, and Alzheimer's disease: food for thought.

Authors:  Ane Otaegui-Arrazola; Pilar Amiano; Ana Elbusto; Elena Urdaneta; Pablo Martínez-Lage
Journal:  Eur J Nutr       Date:  2013-07-27       Impact factor: 5.614

Review 5.  Nutrition and neurodegeneration: epidemiological evidence and challenges for future research.

Authors:  Sophie Gillette-Guyonnet; Marion Secher; Bruno Vellas
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

6.  Bridging the Translation Gap: From Dementia Risk Assessment to Advice on Risk Reduction.

Authors:  Kaarin J Anstey; Ranmalee Eramudugolla; Diane E Hosking; Nicola T Lautenschlager; Roger A Dixon
Journal:  J Prev Alzheimers Dis       Date:  2015

Review 7.  Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Authors:  Joanne J Liu; Pnina Green; J John Mann; Stanley I Rapoport; M Elizabeth Sublette
Journal:  Brain Res       Date:  2014-12-08       Impact factor: 3.252

8.  Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.

Authors:  P A Dacks; D W Shineman; H M Fillit
Journal:  J Nutr Health Aging       Date:  2013-03       Impact factor: 4.075

9.  Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease.

Authors:  Thomas Fraser; Hannah Tayler; Seth Love
Journal:  Neurochem Res       Date:  2009-11-11       Impact factor: 3.996

10.  Characteristics of physical measurement consent in a population-based survey of older adults.

Authors:  Joseph W Sakshaug; Mick P Couper; Mary Beth Ofstedal
Journal:  Med Care       Date:  2010-01       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.